CD15 IHC Test for Hodgkin Lymphoma | Lahalak Platform
A specialized package for detecting classic Hodgkin lymphoma by identifying cancerous Reed-Sternberg cells, ensuring a definitive diagnosis and starting the correct treatment protocol in a timely manner.
Scientific name: Immunohistochemistry: CD15 Diagnostic Package
This diagnostic package, based on immunohistochemistry, includes the examination of a range of markers for the diagnosis and classification of classic Hodgkin lymphoma (cHL). The package primarily involves testing for CD15 (Leu-M1) and CD30 on large, suspicious cells (Reed-Sternberg cells and Hodgkin cells), along with essential complementary marke...
Included Services
- Comprehensive testing of the standard immunological marker panel for the diagnosis of Hodgkin lymphoma (CD15, CD30, PAX5).
- Examination of exclusion markers for B (CD20) and T (CD3) cells to enhance diagnostic accuracy.
- Consult a pathologist specializing in lymphatic system tumors for a comprehensive interpretation of the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- It requires the presentation of a complete tissue block (paraffin block) from the enlarged lymph node biopsy specimen.
- It is necessary to attach the initial pathological report indicating a suspected Reed-Sternberg cell or Hodgkin diagnosis, along with the complete clinical history.
- The patient does not need to fast, as the sample is tissue-based.
- The completion time ranges from 5 to 10 working days.